Deadly Progression of ALS Reversed in an Amazing Stem Cell First

39-year-old Ted Harada was diagnosed with ALS, also known as Lou Gehrig‘s disease. It’s one of the worst diagnoses anyone could get.
He and his doctors expected his health to have severely declined by now. But thanks to an experimental stem cell treatment, he has tossed his cane and is once again playing in the pool with his three kids (…)

Then his neurologist told him about an experiment at Emory University that was recruiting ALS patients to test a stem cell treatment.
The surgeons told Harada that injecting the stem cells into his spine likely would not help him personally, and might even cause harm. But the study would hopefully help scientists find an effective treatment in the future. Harada had nothing to lose and expected nothing – he became study subject number 11 and underwent surgery on March 9 (…)

The Emory surgeons injected 1 million neural stem cells into 10 locations in Harada’s spine (earlier patients received fewer cells; the dosage was gradually increased as the trial progressed). All of the cells came from a single voluntarily aborted and donated two-month-old fetus. Using technology developed by Neuralstem, scientists multiplied the cells and created enough of them to treat all of the patients in this trial and beyond.

“We took one small part of the spinal cord and isolated one million stem cells which are now going to, we hope, treat millions of people around the world,” Dr. Karl Johe, chief scientific officer at Neuralstem told me.

Going into the study, expectations were low. As a safety precaution, the FDA forced the researchers to inject only one-quarter the number of stem cells they originally planned to use. The investigators hoped to show the cells were safe to use, but anticipated little more (…)

The researchers hope the Food and Drug Administration will allow them to add six more patients to the trial so they can collect more data on the treatment’s safety. Neuralstem is also awaiting approval to begin the first phase of a fetal stem cell trial in chronic spinal cord patients.

Unregulated stem cell outlets, such as the one promoted by Republican presidential candidate Rick Perry, claim success treating ALS and just about every other disease you can imagine. But they haven’t gone through the painstaking methodology required to run an FDA-approved human clinical trial, which demands reams of data with the goal of assuring safety and eventually proving efficacy. Such trials can also help convince insurance agencies to cover the treatments. Otherwise, rogue outlets will continue charge up to 10s of thousands of dollars for treatments (…)

read more: http://gizmodo.com/5844786/deadly-progression-of-als-reversed-in-an-amazing-stem-cell-first

Incoming search terms:

als stem cell breakthrough, als research breakthrough, als research breakthrough 2014, als breakthroughs 2014, Als breakthroughs 2013, Breakthroughs in Als 2013, breakthroughs in als 2012, als breakthrough 2014, breakthroughs in als, break through in treating curing als, current treatment for als 2013, 20/27/14 breakthrough on als treament, latest breakthroughs in als 2014, New als Breakthroughs, new breakthroughs in als treatment, bbc als cure, any drug breakthrough for als, a l s breakthrough, ALS Breakthrough 2014 July, als dealy, ALS RESEARCH BREAKTHROUGH 2014 TREATMENT, als reversed, ALS stem cell breakthroughs 2014, any als breakthrough, any breakthroughs in ALS, pluristem als.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>